Use of antrodia camphorata for treating skin conditions
Abstract
The present invention relates to the use of antrodia camphorata in the treatment of skin conditions, such as acne vulgaris, urticaria and eczema, allergic rhinitis, diabetes mellitus and its complications, cancer cachexia, hypercholesterolemia, gout in a subject in need of such treatment. The present invention is also directed to the use of antrodia camphorata in the prevention and treatment of oral cancer and arterial restenosis, in a subject in need of such prevention. The methods comprise the steps of: identifying a subject in need thereof, and administering to the subject a formulation comprising an effective amount of antrodia camphorata, whereby the symptoms in the subject are reduced or prevented. The composition can be a pharmaceutical composition or a nutraceutical composition.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a skin condition in a subject, the method comprising the administering of a composition comprising an effective amount of antrodia camphorate, hereby the symptoms and signs of the skin condition are reduced.
2 . The method according to claim 1 , wherein said skin condition is selected from the group consisting of acne vulgaris, eczema, and urticaria.
3 . The method according to claim 1 , wherein said composition comprises about 1-8 g of dry weight of antrodia camphorata.
4 . The method according to claim 3 , wherein said composition comprises about 4 g of dry weight of antrodia camphorata.
5 . The method according to claim 1 , wherein said composition is a pharmaceutical composition.
6 . The method according to claim 1 , wherein said composition is a nutraceutical composition.
7 . The method according to claim 1 , wherein the said administering is oral administration.Join the waitlist — get patent alerts
Track US2013164321A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.